| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| IRONSHORE (TBA) | BofA Merrill Lynch/ Citigroup/ J.P. Morgan/ UBS Investment Bank | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Advanced Inhalation Therapies (AIT) Ltd. (AITP) | Joseph Gunnar & Co. | 0.33 | $15.00 | $15.00 | $5.00 | n.a. |
| New Terms | ||||||
| Bioventus (BIOV) | J.P. Morgan/ Piper Jaffray | 8.82 | $16.00 | $18.00 | $150.00 | 1-Star |
| Kinsale Capital Group (KNSL) | J.P. Morgan/ William Blair/ RBC Capital Markets | 6.00 | $14.00 | $16.00 | $90.00 | 1-Star |
| TPI Composites (TPIC) | J.P. Morgan/ Morgan Stanley | 6.25 | $11.00 | $12.00 | $71.88 | 1-Star |
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of July 18, 2016 | Manager(s) | Offered | Raised | Price | 7/22/16 | Change |
| IMPINJ (PI) | RBC Capital Markets/ Pacific Crest Securities (a division of KeyBanc Capital Markets)/ Piper Jaffray | 4.80 | $67.20 | $14.00 | $19.56 | 39.71% |
| TPI Composites (TPIC) | J.P. Morgan/ Morgan Stanley | 6.25 | $68.75 | $11.00 | $13.56 | 23.27% |
| Patheon N.V. (PTHN) | J.P. Morgan/ Morgan Stanley/ Jefferies/ UBS Investment Bank | 29.96 | $629.20 | $21.00 | $25.39 | 20.90% |
| Audentes Therapeutics (BOLD) | BofA Merrill Lynch/ Cowen and Company/ Piper Jaffray | 5.00 | $15.00 | $15.00 | 0.00% | |
